SMTL ID : 4oth.1

Crystal Structure of PRK1 Catalytic Domain in Complex with Ro-31-8220

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x DRN: BISINDOLYLMALEIMIDE IX(Non-covalent)

DRN.1: 19 residues within 4Å: Chain A: L.20, G.21, F.25, V.28, A.41, K.43, V.78, M.94, E.95, Y.96, S.97, G.100, D.101, D.143, N.144, L.146, A.156, D.157, F.303 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.25, A:V.28, A:V.28, A:K.43, A:L.146, A:A.156, A:D.157, A:F.303, A:F.303 Hydrogen bonds: A:E.95, A:S.97, A:D.101, A:D.101, A:D.143

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chamberlain, P. et al., Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes. Plos One (2014)

Release Date

2014-08-27

Peptides

Serine/threonine-protein kinase N1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase N1

Related Entries With Identical Sequence